SciELO - Scientific Electronic Library Online

 
vol.32 issue2What can we learn from the errors in management of opioids epidemy in United States of AmericaManagement of corneal ulcer treatment secondary to fungal infection author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista de la OFIL

On-line version ISSN 1699-714XPrint version ISSN 1131-9429

Abstract

SANCHEZ-SANZ, B; GARCIA-MUNOZ, C; ALONSO-PEREZ, L  and  FERRARI-PIQUERO, JM. Very early onset inflammatory bowel disease remission induced with oral gentamicin and vancomycin. Rev. OFIL·ILAPHAR [online]. 2022, vol.32, n.2, pp.203-205.  Epub Feb 13, 2023. ISSN 1699-714X.  https://dx.doi.org/10.4321/s1699-714x2022000200014.

Very early onset inflammatory bowel disease occurs in children under 6 years age. It is frequently associated to a diverse ethiology, dysbiosis being usually described as a triggering factor. Commonly, this population is highly resilient to inmmunosuppressant therapies.

We report here a medical case of a patient diagnosed with unclassified and steroid-dependent colitis, with a year of evolution, who had no responded to intensified therapy at home, and, therefore, was hospitalized at our centre. Treatment with oral antibiotics was intended as remission induction in combination with his usual inmmunomodulator treatment. Although clinical remission was observed at first stage, a new activity outbreak emerged requiring a second round of antibiotics therapy, which was unsuccessful and currently withdrawned.

Keywords : Inflammatory bowel disease; vancomycin; gentamicin.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )